Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuro-Cells in subacute traumatic spinal cord injury
2018-000805-22Phase 2Completed
- Sponsor
- Neuroplast
- Start
- Apr 2019
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute spinal cord injury (SCI) comparing Early Neuro-Cells with Delayed-start Neuro-Cells (initial placebo) (2 arms). Started Apr 2019; status: completed.
02
Drugs
Neuro-Cells
03
Conditions
acute spinal cord injury (SCI)
Beyond the preview
Go deeper on 2018-000805-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000805-22.